Thank you for sharing!

Your article was successfully shared with the contacts you provided.

READINGTON, NJ-Merck & Co. pharmaceutical’s announcement last week that it will close its headquarters here and consolidate space at its existing facility in Summit may have caused more of a whimper than a bang in state real estate circles.

“When you think about it, when Merck acquired Schering-Plough you had two major pharmaceutical companies with their headquarters in New Jersey,” Cushman & Wakefield’s Gualbarto “Gil” Medina was quoted as telling the Newark Star Ledger immediately after the announcement. “I suppose we should have all seen the fact that they’d consolidate in one place or another.”

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.